Mike Hollan

Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.

S-HiCon can reportedly achieve stable liquid formulation for over 200 mg/mL subcutaneous administration.

MedHub has been expanded to work with a wider variety of insurance plans.

Rafaat Rahmani, president and founder of Lifescience Dynamics, grew up in abject poverty, but such hardships—and a later violent brush with racism—would ultimately end up fueling a determined and entrepreneurial path in the life sciences.

Roaldi previously served as chief growth officer for UnitedHealthcare Community & State.

Respondents showed concern for cost increases and changes to benefits.

The campaign comes during a time when the nation is facing a blood shortage.

Announcements such as Apple’s come with pros and cons for industry.

The two companies will continue to collaborate on weight loss medications.

The program will now cover 15 gene and cell therapies.

Sustainable diet habits include behaviors like sticking to a diet plan and avoiding alcohol.

The partnership will provide plan members with access to digital services aimed at older patients.

Pending regulatory approval, the two companies will form a new company named NewCo.

The locations were spread across 37 different states.

The event, part of the #CheckYourFoodTube campaign, was held in Cincinnati, Ohio.

The stop loss is designed to protect against potentially massive costs related to gene therapy treatments.

Dr. Wagner discusses her work with the Bill and Melinda Gates Medical Research Institute.

The campaign is called #BustTheMyth and is aimed at patient education.

The ROGUE device is being developed thanks to a $34.9 million grant from ARPA-H.

Daiichi Sankyo’s head of US oncology business discusses the company’s first DTC television campaign for Enhertu.

Immorta Bio’s president discusses the company’s work with age-related diseases.

The Astellas chief commercial officer discusses the impact that the increase in global and local connectivity has had on commercialization, among other trends.

CSL and Artcurus announced the results of a study on the self-amplifying RNA vaccine.

Corcoran is using her family’s personal story with the disease to promote awareness.

Murphy previously worked at the Biotechnology Innovation Organization as its chief policy officer.

The program, Rx-Performance, will be available starting in January of next year.

The anti-obesity drug maker is raising awareness about the struggle that constant thoughts about food can have on people trying to manage their weight.

The Calliditas Therapeutics CEO discusses her transition from a banker/investor to CEO of a pharma company.

The Octave Bioscience CEO discusses leading the company through commercialization and expansion.

Atossa Therapeutics’ CEO discusses how the new draft guidance will change the way that many women receive their breast exam results.